Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Fragment Pharmacophore-Based Screening: An Efficient Approach for Discovery of New Inhibitors of Toll-Like Receptor 5 Publisher Pubmed



Hashemi H1 ; Hassanzadeh M1 ; Amanlou M1
Authors
Show Affiliations
Authors Affiliations
  1. 1. Faculty of Pharmacy, Department of Medicinal Chemistry and Drug Design, Development Research Center, Tehran University of Medical Sciences, P.O. Box: 14155-6451, Tehran, Iran

Source: Combinatorial Chemistry and High Throughput Screening Published:2016


Abstract

Aim and objective: Rheumatoid Arthritis (RA) is a progressing autoimmune inflammatory disease of joint, hallmarked by inflammation, pain and atrophy of bones. Toll-like receptor 5 (TLR5) is a novel inflammatory mediator in RA, and TLR5 inhibitors are speculated to have a therapeutic potential for the treatment of RA. Material and method: Here we applied fragment pharmacophore-based virtual screening to identify novel TLR5 ligands. Results: Among compounds collected from Otava peptidomimetic compounds, Maybridge fragment and ZINC libraries, 3355 compounds were selected for docking into the flagellin-binding site of TLR5. 16 compounds with the required interaction, critical amino acid residues and the binding free energies <-7 kcal/mol were identified as potential TLR5 inhibitors, one of which was followed up by molecular dynamics simulation. Conclusion: These compounds open a possibility to discover novel TLR5 inhibitors for the treatment of RA. © 2016 Bentham Science Publishers.
Experts (# of related papers)
Other Related Docs
22. Toll-Like Receptors As Targets for Allergen Immunotherapy, Current Opinion in Allergy and Clinical Immunology (2015)
33. Defects in Innate Immunity: Receptors and Signaling Components, Encyclopedia of Infection and Immunity (2022)
43. Computational Design of Trkb Peptide Inhibitors and Their Biological Effects on Ovarian Cancer Cell Lines, International Journal of Peptide Research and Therapeutics (2016)
45. Structure-Based Virtual Screening for Defeating Drug Resistant Form of Egfr Protein, Combinatorial Chemistry and High Throughput Screening (2016)